The world’s first antiaging trial is approved
Five-year study. Recent studies have shown that it can extend the life of roundworms (nematodes) by 57%, and mice’s by 6%. Humans who take metformin are said to live longer, have fewer cardiovascular events and experience a reduced risk of cancer.
The groundbreaking TAME trial that targets aging directly as an endpoint will finally begin this November, revealed lead clinician Dr Nir Bzilai.
Source:
